Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
212.00    1.50 (0.71%)
Bid:
211.00
Ask:
213.00
Spread: 2.00 (0.948%)
Market Cap: £144.65m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Director/PDMR Shareholding

13 Nov 2025 13:32

RNS Number : 4720H
Helios Underwriting Plc
13 November 2025
 

13 November 2025

Helios Underwriting plc

("Helios" or the "Company")

 

Director/PDMR Shareholding

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, was informed on 12 November 2025 that Mr Nigel Hanbury, Non-Executive Deputy Chairman and Director of the Company and persons closely associated with Mr Hanbury, on the same day, sold 92,900 ordinary shares of 10 pence each ("Ordinary Shares") at a price of 210 pence per share and subsequently purchased 92,900 Ordinary Shares at a price of 210.035 pence per share into their Individual Savings Accounts, in order to effect "Bed and ISA" trades. Mr Hanbury's and persons closely associated with Mr Hanbury's total interest remains unchanged at 7,527,680 Ordinary Shares, representing 10.8% of voting rights of the Company.

The notification below, which has been made in accordance with the requirement of the UK Market Abuse Regulation, provides further details.

For further information, please contact:

Helios Underwriting plc

Louis Tucker - Chief Executive Officer +44 (0)203 965 6441 

Adhiraj Maitra - Director of Finance and Operations +44 (0)203 743 2114

 

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7601 6100

 

FTI Consulting

Ed Berry +44 (0)7703 330 199

Christian Harte +44 (0)7974 288 763

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Nigel Hanbury (Director)

Clementine Hanbury (PCA)

Elizabeth Hanbury (PCA)

George Hanbury (PCA)

2

Reason for the notification

a)

Position/status

 

Director

PCA

b)

Initial notification/Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10 pence each

 

ISIN - GB00B23XLS45

b)

Nature of the transaction

 

On market sale of Ordinary Shares and immediate purchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

   

Price(s)

Volume(s)

Sale: 210p

26,700

Sale: 210p

18,000

Sale: 210p

25,550

Sale: 210p

22,650

Purchase: 210.035p

26,700

Purchase: 210.035p

18,000

Purchase: 210.035p

25,550

Purchase: 210.035p

22,650

d)

Aggregated information

 

Price(s)

Volume(s)

Sale: 210p

92,900

Purchase: 210.035p

92,900

e)

Date of the transaction

12 November 2025

f)

Place of the transaction  

 

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXXLFFEFLXFBB
Date   Source Headline
23rd May 20177:00 amRNSQuarterly Syndicate Mid Point Forecasts
4th Apr 20177:00 amRNSAcquisition of Charmac
15th Mar 20177:00 amRNSQuarterly Syndicate Forecasts and Capacity Update
26th Jan 20177:00 amRNSAcquisition of Pooks
9th Jan 20174:34 pmRNSResult of General Meeting
22nd Dec 20167:00 amRNSProposed acquisition of Pooks Limited and GM
5th Dec 20167:01 amRNSUnderwriting Capacity
5th Dec 20167:00 amRNSAcquisition
29th Nov 20167:00 amRNSQuarterly Syndicate Forecasts
1st Nov 20162:56 pmRNSHolding(s) in Company
27th Oct 20161:22 pmRNSResults of GM and of Open Offer and TVR
10th Oct 201610:50 amRNSPosting of circular
6th Oct 20163:36 pmRNSHolding(s) in Company
30th Sep 20162:55 pmRNSResult of Placing and Open Offer Timetable
30th Sep 20167:01 amRNSProposed Placing and Open Offer
30th Sep 20167:00 amRNSHalf-year Report
25th Aug 201610:55 amRNSSyndicate Forecasts
3rd Aug 20164:29 pmRNSTotal Voting Rights
18th Jul 20165:14 pmRNSHolding(s) in Company
6th Jul 20165:30 pmRNSIssue of Equity
6th Jul 20165:30 pmRNSDirector/PDMR Shareholding
29th Jun 20169:35 amRNSResult of AGM
17th Jun 20167:00 amRNSScrip Dividend Reference Price
7th Jun 20165:38 pmRNSHolding(s) in Company
7th Jun 20167:00 amRNSSyndicate Forecasts
1st Jun 20165:41 pmRNSFinal Results - Replacement
31st May 20167:00 amRNSAppointment of Nominated Adviser and Broker
31st May 20167:00 amRNSAcquisition
31st May 20167:00 amRNSFinal Results
11th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20164:39 pmRNSChange of Registered Office
22nd Mar 20167:00 amRNSSyndicate Forecasts
17th Feb 20165:14 pmRNSDirector/PDMR Shareholding
22nd Jan 20167:00 amRNSAcquisition
3rd Dec 201511:34 amRNSSyndicate Forecasts
30th Sep 201510:47 amRNSTotal Voting Rights
25th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20158:19 amRNSAcquisition
24th Aug 20157:00 amRNSSyndicate Forecasts
3rd Aug 20157:00 amRNSAcquisition
15th Jul 20157:00 amRNSAcquisitions
3rd Jul 20151:32 pmRNSDirector/PDMR Shareholding
30th Jun 20157:00 amRNSIssue of Equity
25th Jun 20154:11 pmRNSResult of AGM
19th Jun 201511:47 amRNSDirector/PDMR Shareholding
12th Jun 20155:25 pmRNSCompletion of Acquisition
12th Jun 20157:00 amRNSScript Dividend Reference Price
5th Jun 20157:00 amRNSSyndicate Forecasts
2nd Jun 20159:42 amRNSPosting of Annual Report & Notice of AGM
26th May 20158:06 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.